By Yaël Ossowski As a consumer advocate enamored with technology, there is nothing more satisfying than seeing a new product or service providing a solution to an old problem. The...
By Yaël Ossowski The U.S. Senate is considering two antitrust bills by Sen. Amy Klobuchar that would significantly harm both consumer choice and innovation. Unfortunately, these bills have been co-sponsored...
By Yaël Ossowski In our work promoting smart policies on harm reduction around the world, the Consumer Choice Center is often engaged in battles to stave off vaping flavor bans...
When Donald Trump claimed in September 2020 that every American would have access to vaccines by April 2021, his comments received scorn. The Washington Post said his claims were “without...
The European Commission just published a working document assessing the EU’s orphan and pediatric drug strategies. Read here why incentives for research are key to extending patients’ lives: A rare...
A single drug can cost up to 2 million dollars per treatment. In the light of COVID-19, patient groups and activists have been using the crisis of the moment to...
Last Sunday (April 26th) marked World Intellectual Property Day. While the existence of IP has allowed innovators to enjoy the rewards of their invention, more and more voices speak up...
Thanks to continuous innovation in medical sciences and biotechnology we have seen amazing breakthroughs in medical technology and pharmaceuticals in the past two decades. These breakthroughs would not have been...
In his first speech as Prime Minister, Boris Johnson has delivered a promising outlook for the UK’s tech and agricultural sector, by committing to a more innovation-prospering future after Brexit....
712 H St NE PMB 94982
Washington, DC 20002
Rond Point Schuman 6, Box 5 Brüssel, 1040, Belgien
Golden Cross House, Duncannon Street 8
London, WC2N 4JF, Großbritannien
Block D, Platinum Sentral, Jalan Stesen Sentral 2, Level 3 – 5 Kuala Lumpur, 50470, Malaysia
170 Laurier Ave W, Suite 718, Ottawa, Ontario K1P 5V5
© COPYRIGHT 2025, VERBRAUCHERWAHLZENTRUM
